Skip to content

SYMPOSIUM EVALUATION FORM

Your feedback provides us with vital information that assists in the development of future educational initiatives. 

Thank you for completing the evaluation form.
Learning Objectives

Using a scale of poor to excellent, please indicate your level of confidence in the learning objective as it relates to your knowledge, belief, or behavior, pre-program and post-program.
Describe the physiology of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1)
Poor
Fair
Good
Very Good
Excellent
Before
After
Summarize the efficacy of dual GIP/GLP-1 receptor agonist therapy 
Poor
Fair
Good 
Very Good
Excellent
Before
After
Discuss the safety and practical application of dual GIP/GLP-1 receptor agonist therapy
Poor
Fair
Good
Very Good
Excellent
Before
After
Presentations
Please indicate the level of clarity and effectiveness of the information presented by the speakers:
Poor
Fair
Good
Very Good
Excellent
Dr. Alice Cheng (Chair)
Dr. Richard Dumas
Dr. Julie Lovshin
Dr. Dan Ngui
Educational Deliverables
Please indicate your response to the questions below by applying the following scale:
Strongly Disagree
Disagree
Neutral
Agree
Strongly Agree
The program met my educational expectations
The information provided will contribute to the care of my patients
This program allowed adequate time for interaction (min 25% of the session)
The subject was relevant to my practice
Disclosure of potential conflicts of interest was clearly communicated by all speakers
The program was well organized
Were there any topics you think should have been addressed and/or more carefully covered?
From what you have learned, what will you be able to apply to your practice? And what are the potential barriers?
Please indicate which CanMEDS role(s) you felt were addressed during this educational activity. Check all that apply:
Additional Feedback 
The educational content of the program was balanced and free of commercial or other inappropriate bias.
Please list any topics you would recommend for future programs:
Please share any additional comments:
Thank you!